On 2025-05-14, Journey Medical Corporation (DERM) announced earnings per share of $-0.18 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.24.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-0.06 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.24 | $-0.18 |
| 2025-03-26 | 2024-12-31 | $-0.22 | $0.08 |
| 2024-11-12 | 2024-09-30 | $-0.17 | $-0.12 |
| 2024-08-12 | 2024-06-30 | $-0.15 | $-0.17 |
| 2024-05-13 | 2024-03-31 | $-0.26 | $-0.53 |
| 2024-03-21 | 2023-12-31 | -- | $-0.12 |
| 2023-11-07 | 2023-09-30 | $-0.16 | $0.80 |
| 2023-08-08 | 2023-06-30 | $-0.34 | $-0.46 |
| 2023-05-22 | 2023-03-31 | $-0.44 | $-0.57 |
| 2023-03-29 | 2022-12-31 | $-0.37 | $-0.60 |
| 2022-11-10 | 2022-09-30 | $-0.34 | $-0.57 |
| 2022-08-09 | 2022-06-30 | $-0.25 | $-0.43 |
| 2022-05-10 | 2022-03-31 | $-0.18 | $-0.08 |
| 2022-03-23 | 2021-12-31 | $-0.29 | $-1.64 |
| 2021-12-10 | 2021-09-30 | $-0.87 | $0.32 |
| 2021-11-20 | 2021-06-30 | -- | $-0.11 |